Harbour BioMed and Glenmark Pharmaceuticals Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers Aug 7, 2018 Life Science
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone Aug 7, 2018 Mining
Can a Canadian Penny Stock Company Really Transform the Chinese Commercial Lending Industry? – Partner message from CHF Capital Markets Aug 7, 2018 Technology
Resource Weekly 311 – China tariffs on LNG, oil aim at U.S. energy dominance agenda Aug 7, 2018 Energy, Mining
